KeyBanc analyst Brett Fishbin lowered the firm’s price target on ICU Medical (ICUI) to $173 from $191 to reflect lower industry/peer multiples, while keeping an Overweight rating on the shares. The firm remains encouraged by ICU’s significant progress in demonstrating increased operational and financial stability.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ICUI: